Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$4.78 - $8.26 $191,200 - $330,400
-40,000 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$4.0 - $21.53 $1.37 Million - $7.37 Million
-342,300 Reduced 89.54%
40,000 $160,000
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $5.33 Million - $9.22 Million
382,300 New
382,300 $8.2 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $210M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Atlas Principals, LLC Portfolio

Follow Atlas Principals, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Principals, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Principals, LLC with notifications on news.